Cytotoxic effect of amide derivatives of trifluoromethionine against the enteric protozoan parasite Entamoeba histolytica
Introduction
Amoebiasis is an infectious disease caused by the enteric protozoan parasite Entamoeba histolytica and is the second leading cause of death from parasitic diseases after malaria. Only metronidazole and related compounds are commonly used against invasive intestinal and extraintestinal amoebiasis [1], [2]. Although clinical resistance against metronidazole has not yet been demonstrated, sporadic cases of treatment failure have been reported [1]. In addition, it has been shown that this parasite easily adapts to therapeutic levels of metronidazole in vitro [3]. Resistance to metronidazole is also acquired easily by many bacterial species as well as Giardia intestinalis and Trichomonas vaginalis[1]. Therefore, the development of a novel antiamoebic drug is urgently required.
Pathways present exclusively in microorganisms but missing in humans may potentially represent a rational target for drug development. Entamoeba histolytica has several unique metabolic features. It lacks both the forward and reverse trans-sulphuration pathways that convert methionine to cysteine via cystathionine or vice versa, whilst it possesses l-methionine γ-lyase (MGL) (EC. 4.4.1.11) to decompose methionine, homocysteine and cysteine and produces ammonia, α-keto acid and volatile thiols [4]. MGL is present in only limited lineages of bacteria, parasitic protozoa and plants but is absent in mammals (see in [5]). In E. histolytica, two isoenzymes of MGL (MGL1 and MGL2) with distinct substrate specificities have been identified [5].
Trifluoromethionine (TFM), also know as S-trifluoromethyl-l-homocysteine, a fluorinated analogue of methionine, has been shown to be highly toxic to bacteria, Porphyromonas gingivalis, T. vaginalis and E. histolytica in vitro [6], [7], [8], [9]. It was also reported to treat infections by P. gingivalis and T. vaginalis in a rodent model [7], [8]. In the present study, the in vitro and in vivo efficacy of TFM and its derivatives were examined to gain insight into the structure–activity relationship and to determine the mechanism underlying their mode of action.
Section snippets
Chemical synthesis of trifluoromethionine and its derivatives
The synthetic scheme and structure of TFM and its analogues are shown in Supplementary Fig. 1.
Parasites and cultivation
Trophozoites of E. histolytica HM-1:IMSS cl6 were cultured axenically in BIS medium at 35.5 °C as described previously [10].
In vitro cytotoxicity assay of trifluoromethionine derivatives against Entamoeba histolytica trophozoites and Chinese hamster ovary (CHO) cells
Approximately 5 × 103 amoebae in 280 μL of medium were seeded into each well of a 96-well plate and incubated with various concentrations of TFM derivatives for 48 h. Following incubation, the amoebae were washed with 100 μL of pre-warmed Opti-MEM® I (Invitrogen, Carlsbad, CA) and
Results and discussion
The in vitro cytotoxicities of TFM, 15 TFM derivatives and 4 control compounds lacking fluorine were evaluated by measuring their 50% inhibitory concentration (IC50) values against E. histolytica trophozoites (Table 1). Whilst TFM showed an IC50 of 7.34 μM, the derivatives TFM-01 and TFM-02 had IC50 values of 2.22–2.28 μM. Three difluoroanilide compounds [2,3-difluoroanilide (TFM-03), 2,6-difluoroanilide (TFM-04) and 2,5-difluoroanilide (TFM-05)] also had a comparable 2.5–3.0-fold reduction in
Acknowledgments
The authors thank Rumiko Kosugi (Department of Parasitology, Gunma University Graduate School of Medicine, Gunma, Japan) for technical assistance. They also thank Mr Yuji Kakazu and Mr Akiyoshi Hirayama (Institute for Advanced Biosciences, Keio University, Yamagata, Japan) for technical help with mass spectrometry.
Funding: This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to DS (20590429) and TN (
References (18)
- et al.
Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase
J Biol Chem
(1999) - et al.
A versatile bacterial enzyme: l-methionine γ-lyase
Enzyme Microb Technol
(1985) - et al.
l-Methionine-γ-lyase, as a target to inhibit malodorous bacterial growth by trifluoromethionine
Biochem Biophys Res Commun
(2002) - et al.
Identification and characterization of two isoenzymes of methionine γ-lyase from Entamoeba histolytica: a key enzyme of sulfur-amino acid degradation in an anaerobic parasitic protist that lacks forward and reverse trans-sulfuration pathways
J Biol Chem
(2003) - et al.
Amino acid consumption by the parasitic, amoeboid protists Entamoeba histolytica and E. invadens
FEMS Microbiol Lett
(1995) - et al.
Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by “amitochondriate” protozoan parasites
Clin Microbiol Rev
(2007) - et al.
Metronidazole. A therapeutic review and update
Drugs
(1997) - et al.
Kinetic characterization of methionine γ-lyases from the enteric protozoan parasite Entamoeba histolytica against physiological substrates and trifluoromethionine, a promising lead compound against amoebiasis
FEBS J
(2008) - et al.
dl-S-Trifluoromethylhomocysteine, a novel inhibitor of microbial growth
Can J Microbiol
(1966)
Cited by (39)
Gamma cleavage is a rate-determining step in the gamma-elimination reaction of L-methionine analogues catalyzed by methionine-gamma-lyase
2021, Biochimica et Biophysica Acta - Proteins and ProteomicsEnantioselective Michael Addition Reactions to Construct SCF<inf>3</inf>-containing Stereocenter Catalyzed by Chiral Quaternary Phosphonium Salts
2020, Advanced Synthesis and CatalysisSulfoxides of sulfur-containing amino acids are suicide substrates of Citrobacter freundii methionine γ-lyase. Structural bases of the enzyme inactivation
2020, BiochimieCitation Excerpt :There are few data on the possibility to use MGL inhibitors as antimicrobial drugs. The inhibition of T. vaginalis, P. gingivalis, and E. histolytica growth by thiocarbonyl difluoride, the product of the γ-elimination reaction of trifluoro-l-methionine catalyzed by MGL, has been demonstrated in vitro and in vivo [22,23]. It was shown that myrsinoic acid B inhibited α-ketobutyrate production by Fusobacterium nucleatum JCM8532, P. gingivalis W83, and T. denticola ATCC35405 [24].
Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival
2019, Journal of Global Antimicrobial ResistanceCitation Excerpt :Metronidazole resistance in E. histolytica is strongly connected with the upregulation of iron-containing superoxide dismutase and peroxiredoxin and this resistance property is also linked with the downregulation of ferredoxin 1 and flavin reductase [69]. Presently, trifluoromethionine has been revealed as an effective amoebicide against E. histolytica [70]. However, its mechanism of resistance in E. histolytica has also been established [71,72].
- 1
Present address: Department of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna 800007, India.